INTER-INSTITUTE PROGRAM FOR THE DEVELOPMENT OF AIDS-RELATED THERAPEUTICS

RELEASE DATE:  September 22, 2003

NOTICE:  NOT-CA-03-038

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov)
National Cancer Institute (NCI)
 (http://www.nci.nih.gov)

LETTER OF INTENT:  November 1, 2003
APPLICATION RECEIPT DATE:  December 1, 2003

The Inter-Institute Program for the Development of AIDS-Related Therapeutics 
(IIP) is co-sponsored by The National Institute of Allergy and Infectious 
Diseases (NIAID) and National Cancer Institute (NCI).  Investigators are invited 
to submit proposals to this drug development program.  IIP is designed to help 
AIDS research investigators facilitate the preclinical development of: 
1) therapies for the treatment of HIV disease, AIDS-associated malignancies, 
opportunistic infections and tuberculosis associated with AIDS, and 
2) microbicide-based prevention strategies for HIV.  IIP does not fund grants.  
Instead, applications to the program are requests to use IIP drug development 
resources to conduct specific tasks the applicants themselves are unable to 
carry out in their efforts to translate basic research findings to applied or 
clinical practice.  Examples of tasks that may be requested include High 
Throughput Screen (HTS) assay development, evaluation in animal efficacy models, 
Good Manufacturing Practice (GMP) scale-up synthesis of small molecules and 
biologics, clinical dosage formulation and manufacturing, and Good Laboratory 
Practice (GLP) toxicology.  Program proposals are solicited twice per year on 
June 1 and December 1 and reviewed in a competitive manner.  

The current deadline for receipt of applications is December 1, 2003; no later 
than November 1, 2003 a Letter of Intent must be submitted to the 
Inter-Institute Program Coordinator.  Further information about this program, 
including detailed instructions for preparing proposals and the Letter of 
Intent, can be found at the program web site at 
http://dtp.nci.nih.gov/docs/dart.html

INQUIRIES: 

Inquiries regarding this initiative maybe directed to:

IIP Coordinator
6130 Executive Boulevard, Room 8022
Rockville, MD 20852 
Telephone:. 301-496-8720
E-mail:  iip@dtpax2.ncifcrf.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.